Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis.

CONCLUSION: In patients with T1D, liraglutide might offer as adjunct to insulin, improving glycemic control, inducing body weight loss and decreasing exogenous insulin requirements and severe hypoglycemia.
PMID: 31203802 [PubMed - as supplied by publisher]

Source: Current Diabetes Reviews - June 13, 2019 Category: Endocrinology Authors: Dimitrios P, Michael D, Vasilios K, Konstantinos S, Konstantinos I, Ioanna Z, Konstantinos P, Spyridon B, Asterios K Tags: Curr Diabetes Rev Source Type: research